Journal
CELL METABOLISM
Volume 27, Issue 6, Pages 1163-1165Publisher
CELL PRESS
DOI: 10.1016/j.cmet.2018.05.014
Keywords
-
Categories
Ask authors/readers for more resources
Drugs that target angiogenesis are commonly used for treating various cancers, but their clinical benefits are limited. In a recent Science Translational Medicine article, Incio et al. (2018) provide mechanistic insight on the role of obesity in the development of anti-VEGF drug resistance in human patients and murine models of breast cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
